Literature DB >> 28611551

First Two Cases of Bloom Syndrome in Russia: Lack of Skin Manifestations in a BLM c.1642C>T (p.Q548X) Homozygote as a Likely Cause of Underdiagnosis.

Evgeny N Suspitsin1,2, Farida I Sibgatullina3, Lydia V Lyazina4, Evgeny N Imyanitov1,2,5,6.   

Abstract

Bloom syndrome (BS) is an exceptionally rare hereditary disease. Typical manifestations of BS usually include growth deficiency, a characteristic facial appearance, skin hypersensitivity to ultraviolet irradiation, and a strong predisposition to early-onset cancers. We have previously described a recurrent BLM c.1642C>T (p.Q548X) mutation, which is present in heterozygous state in 0.2-0.6% of individuals of Slavic origin. Despite the high occurrence of this founder allele, BS has not yet been described in patients of Slavic ethnicity. Here, we present 2 cases of BS, which were missed by standard genetic counseling and were eventually identified entirely due to chance. Our patients show the need for further investigations to confirm whether the atypical appearance of BS is indeed characteristic for biallelic carriers of the c.1642C>T (p.Q548X) allele and whether the absence of skin manifestations contributes to the underdiagnosis of the disease in Russia. Therefore, we suggest that all Slavic patients with only one single clinical feature of BS are to be screened for this allele and subjected to further analysis wherever appropriate. In addition to identifying new BS patients, this effort will help to clarify the frequency of "atypical BS" with incomplete phenotypic manifestations.

Entities:  

Keywords:  Bloom syndrome; Immune deficiency; Photosensitivity; Recurrent mutations; Short stature

Year:  2017        PMID: 28611551      PMCID: PMC5465803          DOI: 10.1159/000454820

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  13 in total

1.  Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.

Authors:  B B Roa; C V Savino; C S Richards
Journal:  Genet Test       Date:  1999

2.  Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs; probably a syndrome entity.

Authors:  D BLOOM
Journal:  AMA Am J Dis Child       Date:  1954-12

3.  Syndrome-causing mutations of the BLM gene in persons in the Bloom's Syndrome Registry.

Authors:  James German; Maureen M Sanz; Susan Ciocci; Tian Z Ye; Nathan A Ellis
Journal:  Hum Mutat       Date:  2007-08       Impact factor: 4.878

4.  BLM heterozygosity and the risk of colorectal cancer.

Authors:  Stephen B Gruber; Nathan A Ellis; Karen K Scott; Ronit Almog; Prema Kolachana; Joseph D Bonner; Tomas Kirchhoff; Lynn P Tomsho; Khedoudja Nafa; Heather Pierce; Marcelo Low; Jaya Satagopan; Hedy Rennert; Helen Huang; Joel K Greenson; Joanna Groden; Beth Rapaport; Jinru Shia; Stephen Johnson; Peter K Gregersen; Curtis C Harris; Jeff Boyd; Gad Rennert; Kenneth Offit
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

5.  High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.

Authors:  Anna P Sokolenko; Aglaya G Iyevleva; Elena V Preobrazhenskaya; Nathalia V Mitiushkina; Svetlana N Abysheva; Evgeny N Suspitsin; Ekatherina Sh Kuligina; Tatiana V Gorodnova; Werner Pfeifer; Alexandr V Togo; Elena A Turkevich; Alexandr O Ivantsov; Dmitry V Voskresenskiy; Georgy D Dolmatov; Elena M Bit-Sava; Dmitry E Matsko; Vladimir F Semiglazov; Iduna Fichtner; Alexey A Larionov; Sergey G Kuznetsov; Antonis C Antoniou; Evgeny N Imyanitov
Journal:  Int J Cancer       Date:  2011-10-20       Impact factor: 7.396

6.  The frequency of the BLM p.Q548X (c.1642C>T) mutation in breast cancer patients from Russia is no higher than in the general population.

Authors:  Maksim S Anisimenko; Anton E Kozyakov; Galina A Paul; Sergey P Kovalenko
Journal:  Breast Cancer Res Treat       Date:  2014-11-16       Impact factor: 4.872

Review 7.  Bloom syndrome.

Authors:  Harleen Arora; Anna H Chacon; Sonal Choudhary; Michael P McLeod; Lauren Meshkov; Keyvan Nouri; Jan Izakovic
Journal:  Int J Dermatol       Date:  2014-03-06       Impact factor: 2.736

8.  Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.

Authors:  Natalia Bogdanova; Alexandr V Togo; Magdalena Ratajska; Wojtek Kluźniak; Zalina Takhirova; Theresa Tarp; Darya Prokofyeva; Marina Bermisheva; Grigoriy A Yanus; Tatiana V Gorodnova; Anna P Sokolenko; Alina Kuźniacka; Amira Podolak; Maciej Stukan; Dominika Wokołorczyk; Jacek Gronwald; Danuta Vasilevska; Vilius Rudaitis; Ingo B Runnebaum; Matthias Dürst; Tjoung-Won Park-Simon; Peter Hillemanns; Natalia Antonenkova; Elza Khusnutdinova; Janusz Limon; Jan Lubinski; Cezary Cybulski; Evgeny Imyanitov; Thilo Dörk
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

Review 9.  Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition.

Authors:  Christopher Cunniff; Jennifer A Bassetti; Nathan A Ellis
Journal:  Mol Syndromol       Date:  2016-11-05

Review 10.  Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.

Authors:  Zdenek Kleibl; Vessela N Kristensen
Journal:  Breast       Date:  2016-06-16       Impact factor: 4.380

View more
  2 in total

1.  Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer.

Authors:  Julie L Boyle; Andrew W Hahn; Ashley L Kapron; Wendy Kohlmann; Samantha E Greenberg; Timothy J Parnell; Craig C Teerlink; Benjamin L Maughan; Bing-Jian Feng; Lisa Cannon-Albright; Neeraj Agarwal; Kathleen A Cooney
Journal:  JCO Precis Oncol       Date:  2020-03-04

2.  Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer.

Authors:  Wojciech Kluźniak; Dominika Wokołorczyk; Bogna Rusak; Tomasz Huzarski; Aniruddh Kashyap; Klaudia Stempa; Helena Rudnicka; Anna Jakubowska; Marek Szwiec; Sylwia Morawska; Katarzyna Gliniewicz; Karina Mordak; Małgorzata Stawicka; Joanna Jarkiewicz-Tretyn; Magdalena Cechowska; Paweł Domagała; Tadeusz Dębniak; Marcin Lener; Jacek Gronwald; Jan Lubiński; Steven A Narod; Mohammad R Akbari; Cezary Cybulski
Journal:  Cancers (Basel)       Date:  2019-10-13       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.